Reason for request
Assessment of the dosage change permitting use in children.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
The medicinal product SMOFLIPID has the same actual benefit in the paediatric population as previously recognised by the transparency Committee in adults (IAB V). |
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
gvv67n72e1KX2A5K
